Dicerna pharmaceuticals, inc. (DRNA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
CASH FLOWS FROM OPERATING ACTIVITIES:
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-116,797

-120,459

-99,400

-87,630

-99,428

-88,853

-85,983

-81,996

-61,578

-60,200

-58,481

-57,624

-58,021

-59,513

-61,126

-63,894

-64,448

-62,839

-61,794

-56,040

-51,219

-47,939

-40,068

-33,072

-25,503

-18,518

0

0

0

Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation expense

22,522

18,822

15,930

13,083

10,968

7,888

7,440

7,262

7,510

7,770

8,101

8,403

8,787

9,165

9,425

9,546

9,797

9,732

9,387

8,601

8,345

8,237

6,566

5,052

2,674

495

0

0

0

Depreciation and amortization expense

1,547

1,254

1,096

946

847

800

809

830

837

800

744

749

751

800

825

802

770

727

958

926

842

848

600

730

774

740

0

0

0

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium on investments

2,525

3,559

3,915

3,228

2,261

1,126

665

399

252

169

-244

-172

-102

-73

99

145

149

134

0

0

0

-

-

-

-

-

-

0

0

Non-cash lease expense

4,105

2,747

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Increase in fair value of preferred stock warrant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,559

2,214

2,556

2,438

-126

0

0

0

Changes in operating assets and liabilities:
Litigation settlement payable

0

-10,500

-12,797

-8,904

0

10,500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

362,984

211,803

173,001

176,217

180,354

173,916

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and license receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,018

0

0

0

Prepaid expenses and other assets

11,544

3,856

6,091

1,222

-414

-532

-816

759

-300

1,459

2,077

1,480

1,536

414

18

-440

-173

177

1,038

791

519

1,171

632

945

580

-57

0

0

0

Accounts payable

1,960

2,067

363

1,741

2,742

-1,217

-1,877

62

-2,077

626

1,775

465

1,679

1,644

2,234

1,564

632

1,384

155

575

1,049

-97

-362

356

52

116

0

0

0

Contract receivables

15,000

100,354

3,000

0

0

100,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

10,734

9,487

10,769

4,267

1,527

3,974

2,218

434

385

-411

-1,018

-633

716

-542

-1,866

-717

533

2,240

4,458

3,890

2,339

2,656

2,964

2,523

1,498

1,016

0

0

0

Lease liability

10,641

8,966

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

37

45

53

60

0

0

0

Net cash provided by operating activities

248,105

-692

75,872

96,803

107,036

18,298

-49,296

-50,702

-48,769

-45,327

-50,963

-50,103

-47,489

-48,747

-50,427

-52,126

-52,419

-48,799

-47,854

-42,708

-38,965

-34,764

-28,068

-22,494

-18,437

-10,944

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Maturities of held-to-maturity investments

414,000

418,000

337,000

274,000

149,000

81,000

75,000

80,000

75,000

70,000

60,000

55,000

58,000

48,500

50,000

76,000

68,000

70,000

0

0

0

-

-

-

-

-

-

-

-

Purchases of held-to-maturity investments

661,824

362,120

464,592

475,868

303,033

283,372

0

0

0

-

-

-

-

35,031

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

5,449

6,349

5,428

4,042

2,505

359

245

248

209

133

207

228

380

449

514

774

827

1,134

1,998

1,844

2,291

2,013

0

0

0

-

-

-

-

Other

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from public offering of common stock, net of transaction costs (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94,148

0

0

0

-

-

-

-

Net cash (used in) provided by investing activities

-253,258

49,531

-133,020

-205,910

-156,538

-202,731

-88,810

10,151

-44,718

-19,852

-20,075

-10,151

42,605

13,020

29,471

55,211

11,292

33,001

23,120

-55,290

-68,539

-75,761

0

0

0

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of placement agent commissions

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of common stock offering costs

0

50

753

753

753

703

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercises of stock options and issuances under Employee Stock Purchase Plan

7,502

7,110

1,120

2,044

1,639

2,110

1,907

1,111

871

290

215

155

154

561

585

668

696

427

0

0

0

-

-

-

-

-

-

-

-

Other

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercised stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Settlement of restricted stock for tax withholding

-

-

-

-

-

35

35

35

35

11

11

11

11

27

28

28

28

76

0

0

0

-

-

-

-

-

-

-

-

Repayments of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,026

6,102

7,148

4,246

4,140

0

0

0

Net cash provided by financing activities

92,510

52,888

60,779

169,802

169,397

169,883

153,173

43,828

113,288

112,731

69,454

69,844

143

534

557

194

46,106

45,789

45,862

46,174

-3,653

89,997

87,634

143,271

149,068

54,282

0

0

0

NET INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH EQUIVALENTS

87,357

101,727

3,627

60,695

119,895

-14,550

15,067

3,277

19,801

47,552

-1,584

9,590

-4,741

-35,193

-20,399

3,279

4,979

29,991

21,128

-51,824

-111,157

-20,528

-22,897

75,891

130,062

42,925

0

0

0

NONCASH OPERATING ACTIVITIES
Right-of-use assets acquired through operating leases

26,159

25,725

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Redeemable convertible preferred stock issuance costs included in accounts payable

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NONCASH INVESTING ACTIVITIES
Property and equipment purchases included in accounts payable and accrued expenses

123

727

1,604

2,169

2,511

1,648

0

0

0

-

-

-

21

53

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

NONCASH FINANCING ACTIVITIES
Common stock offering costs included in accounts payable or accrued expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use assets acquired through financing leases

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant conversion to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,088

0

0

0

-

-

-

-